Regulation of immunity in bronchiectasis

Medical Mycology

Volumn 47, Issue SUPPL. 1, 2009, Pages

  Boyton, R J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

ABPA; Bronchiectasis; HLA; Lung; NK cells

Indexed keywords

ANTIFUNGAL AGENT; CHEMOKINE RECEPTOR CXCR1; GAMMA INTERFERON; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DQ5 ANTIGEN; HLA DR1 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; UNCLASSIFIED DRUG; HLA-DQ5 ANTIGEN;

ADAPTIVE IMMUNITY; ADJUVANT THERAPY; ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BRONCHIECTASIS; BRONCHOPULMONARY ASPERGILLOMA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; GENOTYPE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HOMOZYGOSITY; HUMAN; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; LUNG INJURY; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOSIS; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; ULCERATIVE COLITIS; GENETICS; IMMUNOLOGY; PATHOLOGY; REVIEW;

ASPERGILLUS; BACTERIA (MICROORGANISMS);

BRONCHIECTASIS; DISEASE SUSCEPTIBILITY; HLA-DQ ANTIGENS; HLA-DR1 ANTIGEN; HUMANS; KILLER CELLS, NATURAL;

EID: 67651085703     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802163370     Document Type: Article

References (23)

1. Barker AF. Bronchiectasis. N Engl J Med 2002; 346: 1383-1393.
2. Wilson R, Boyton R. Bronchiectasis. In Laurent GJ, Shapiro SD (eds). Encyclopedia of respiratory medicine. Oxford, UK: Elsevier, 2006 259-268.
3. Hansell D. Bronchiectasis. Radiol Clin North Am 1998; 36: 107-28.
4. Singleton R, Morris A, Redding G, et al. Bronchiectasis in Alaska Native children causes and clinical courses. Pediatr Pulmonol 2000; 29: 182-187.
5. Callahan CW. Bronchiectasis abated or aborted? Respiration 2005; 72: 225-226.
6. Twiss J, Metcalfe R, Edwards E, et al. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child 2005; 90: 737-740.
7. Chang AB, Grimwood K, Mulholland EK, et al. Bronchiectasis in indigenous children in remote Australian communities. Med J Aust 2002; 177: 200-204.
8. Clark NS. Bronchiectasis in childhood. Br Med J 1963; 1: 80-88.
9. Sayajakangas O, Keistinen T, Tuuponen T, et al. Evaluation of the incidence and age distribution of bronchiectasis from the Finnish Hospital Discharge Register. Cent Eur J Public Health 1998; 6 235-237.
10. Morrissey BM, Harper RW. Bronchiectasis: Sex and gender considerations. Clin Chest Med 2004; 25: 361-372.
11. Cohen M, Sahn SA. Bronchiectasis in systemic disease. Chest 1999; 116: 1063-1074.
12. Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation of causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000; 162: 1277-1284.
13. Wickremasinghe M, Ozerovitch LJ, Davies G, et al. Nontuberculosis mycobecteria in patients with bronchiectasis. Thorax 2005; 60 1045-1051.
14. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Eng J Med 1996; 335: 1941-1949.
15. Kunst H, Wickremasinghe M, Wells A, et al. Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. Eur Respir J 2006; 28: 352-457.
16. Kelleher P, Goodsall A, Mulgirigama A, et al. Interferon-γ therapy in two patients with progressive chronic pulmonary aspergillosis. Eur Respir J 2006; 27: 1307-1310.
17. Boyton R, Reynolds C, Wahid F, et al. IFN g and CXCR-1 gene polymorphisms in idiopathic bronchiectasis. Tissue Antigens 2006; 68: 325-330.
18. Lopez-Maderuelo D, Arnalich F, Serantes R, et al. Interferon-γ and IL-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 2003; 167: 970-975.
19. Singh B, Read S, Asseman C, et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001; 182: 190-200.
20. Boyton RJ, Smith J, Jones M, et al. Human leucocyte antigen (HLA) class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity. Clin Exp Immunol 2007; 149: 1-8.
21. Gadola SD, Mains-Teissererc HT, Trowsdale J, et al. TAP deficiency syndrome. Clin Exp Immunol 2000; 121: 173-178.
22. Boyton RJ, Smith J, Ward R, et al. HLA-C and killer cell immunoglobulin-like receptor (KIR) genes in susceptibility to bronchiectasis. Am J Respir Crit Care Med 2006; 176: 327-333.
23. Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol 2007; 149: 1-8.